KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $79.3 million.

  • Ginkgo Bioworks Holdings' Accumulated Expenses rose 462.6% to $79.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.3 million, marking a year-over-year increase of 462.6%. This contributed to the annual value of $65.4 million for FY2024, which is 4058.48% down from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Accumulated Expenses is $79.3 million, which was up 462.6% from $57.2 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Accumulated Expenses peaked at $122.6 million during Q1 2023, and registered a low of $53.6 million during Q3 2021.
  • For the 5-year period, Ginkgo Bioworks Holdings' Accumulated Expenses averaged around $89.7 million, with its median value being $88.8 million (2022).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 20595.64% in 2021, then plummeted by 5113.39% in 2025.
  • Ginkgo Bioworks Holdings' Accumulated Expenses (Quarter) stood at $93.3 million in 2021, then grew by 22.89% to $114.7 million in 2022, then fell by 4.05% to $110.1 million in 2023, then tumbled by 40.58% to $65.4 million in 2024, then grew by 21.34% to $79.3 million in 2025.
  • Its Accumulated Expenses was $79.3 million in Q3 2025, compared to $57.2 million in Q2 2025 and $70.7 million in Q1 2025.